Discovery

Additional stories, diving deep into the working ways at Novartis, can be found within our live magazine.

The magazine format brings an emerging experience to life of the various stories that Novartis has to tell.

Discovery

It can take years of sleuthing to produce breakthrough medicines. Read more about our approach to research. 

Subscribe
3D rendering of coronavirus disease (COVID-19), the novel coronavirus causing the pand

Moving from speculation to science during a pandemic

3D rendering of a COVID-19 virus

It takes an R&D village to fight a pandemic

SARS-CoV-2 is the virus that causes coronavirus disease (COVID-19)

Clinical trial comes together in weeks to address coronavirus

Transmission electron microscopic image of an isolate from a case of COVID-19

COVID-19: Answering your top questions

Molecular glues bring proteins together

Visualizing molecular glues

Color illustration showing several scientists in front of a large-scale computer highlighting the number 42

The data42 program shows Novartis’ intent to go big on data and digital

Achim Plueckebaum, Peter Speyer and Pascal Bouquet of data42

Meet Achim, leading the data42 program

Scientists are working to develop drugs for individuals living with sickle cell disease

Shaping the future of sickle cell disease

Phil Gotwals discusses advanced therapy platforms.

Sourcing innovation, strategically